Shannon Elaine Mary's Form 4 filing
Takeda Pharmaceutical Co Ltd (TAK) · filed Aug 12, 2026
- Accession no.
- 0001493152-26-037352
- Filed
- Aug 12, 2026, 4:10 PM ET
- Trade date
- Aug 11, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $357.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shannon Elaine MaryCIK 0002009368 | Officer (Pres., Global Supply & Quality) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | American Depositary Shares | SSaleDisposed | −20,363 | $17.55 | −$357,370.65 | 67,311 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.